News

Drawing on HealthTech Alpha's unrivalled dataset of more than 2 billion digital health data points, including the activities of 16,100 investors worldwide, it offers one of the most granular views yet of capital, clinical evidence and ecosystem power in digital health. In an era of tighter capital and slower exits, backing companies with strong Alpha, Momentum and Partnership Scores is no longer a nice to have", it is increasingly the difference between portfolios that compound value and those that stall in mid-stage limbo. The Investor Score combines direct metrics – such as the number of new digital health investments between January 2022 and June 2025, exits completed over the same period, and the count of portfolio companies valued above USD 100 million – with indirect metrics that capture portfolio quality and ecosystem fit. The company's work ranges from global digital health market scans and bespoke landscape analyses, through portfolio and partnership benchmarking, to the production of widely used reference indices such as the Pharmaceutical Digital Health Innovation Index, and to thematic deep dives into areas such as clinical trials and US health systems."